CBAYUSD
Cymabay Therapeutics Inc
Clinical-stage biopharmaceutical company developing therapies for chronic liver and metabolic diseases including seladelpar for primary biliary cholangitis
CUSIP: 23257D103HealthcareUS1 holder
Total Value
$3.64M
Total Shares
280.0K
Net Share Change
+280.0K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Leon Cooperman
$3.64M280.0K sharesNEW